Aarey Drugs and Pharmaceuticals Ltd
AAREYDRUGSAarey Drugs and Pharmaceuticals Ltd
AAREYDRUGS
Price Chart
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 23.84 | 1.24 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 51.70 | 6.65 | 0.52% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Aarey Drugs & Pharmaceuticals is engaged in active pharmaceutical ingredient (API)/Bulk Drugs manufacturing.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Mankind Pharma Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 249.17 | 399.31 | 352.53 | 359.08 | 306.78 | 355.43 | 495.43 | 421.69 | 402.58 | 525.91 | ||||||||||
Raw Materials | 240.94 | 386.12 | 346.93 | 347.45 | 285.93 | 335.96 | 461.35 | 418.98 | 387.76 | 512.71 | ||||||||||
| Power & Fuel Cost | 0.04 | 0.04 | 0.04 | 0.04 | 0.01 | 0.00 | 0.04 | 0.03 | 0.03 | |||||||||||
| Employee Cost | 0.26 | 0.34 | 0.35 | 0.37 | 0.29 | 0.20 | 0.67 | 0.63 | 0.54 | |||||||||||
| Selling & Administrative Expenses | 1.49 | 2.62 | 3.04 | 3.82 | 4.94 | 3.88 | 6.89 | 4.52 | 7.83 | |||||||||||
| Operating & Other expenses | 2.29 | -2.76 | -8.65 | -4.83 | 5.69 | 3.73 | 12.42 | -12.93 | -4.99 | |||||||||||
EBITDA | 4.15 | 12.95 | 10.82 | 12.23 | 9.92 | 11.66 | 14.06 | 10.46 | 11.41 | 13.20 | ||||||||||
| Depreciation/Amortization | 0.62 | 0.64 | 0.71 | 1.01 | 0.89 | 0.92 | 1.99 | 1.57 | 1.70 | 4.68 | ||||||||||
| PBIT | 3.53 | 12.31 | 10.11 | 11.22 | 9.03 | 10.74 | 12.07 | 8.89 | 9.71 | 8.52 | ||||||||||
| Interest & Other Items | 1.72 | 4.33 | 1.92 | 2.23 | 1.79 | 2.44 | 2.04 | 2.87 | 4.38 | 1.83 | ||||||||||
| PBT | 1.81 | 7.98 | 8.19 | 8.99 | 7.24 | 8.30 | 10.03 | 6.02 | 5.33 | 6.69 | ||||||||||
| Taxes & Other Items | 0.52 | 2.51 | 2.01 | 2.44 | 1.45 | 1.78 | 3.48 | 2.24 | 0.66 | -0.21 | ||||||||||
| Net Income | 1.29 | 5.47 | 6.18 | 6.55 | 5.79 | 6.52 | 6.55 | 3.78 | 4.67 | 6.90 | ||||||||||
| EPS | 0.77 | 3.13 | 2.98 | 2.80 | 2.48 | 2.79 | 2.69 | 1.49 | 1.75 | 2.46 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Aarey Drugs and Pharmaceuticals Ltd | 35.22 | 1.24 | — |
| Sun Pharmaceutical Industries Ltd | 45.46 | 6.49 | 0.74% |
| Mankind Pharma Ltd | 64.67 | 12.92 | — |
| Cipla Ltd | 28.92 | 4.45 | 0.88% |
Price Comparison
Compare AAREYDRUGS with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Decreased Total Retail Holding
In last 3 months, retail holding in the company has decreased by 1.10%
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
AAREYDRUGS has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateDec 13, 2018
Dividend/Share
₹0.10
Ex DateEx Date
Dec 13, 2018
Aarey Drugs & Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 2 January 2025 .Powered by Capital Market - Live
Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 4 December 2024Powered by Capital Market - Live
Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 November 2024Powered by Capital Market - Live
Net profit of Aarey Drugs & Pharmaceuticals rose 30.08% to Rs 1.60 crore in the quarter ended September 2024 as against Rs 1.23 crore during the previous quarter ended September 2023. Sales rose 81.81% to Rs 105.14 crore in the quarter ended September 2024 as against Rs 57.83 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales105.1457.83 82 OPM %3.553.20 - PBDT3.262.28 43 PBT1.751.01 73 NP1.601.23 30 Powered by Capital Market - Live
Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 1 October 2024.Powered by Capital Market - Live
Aarey Drugs & Pharmaceuticals announced that the 34th Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
Net profit of Aarey Drugs & Pharmaceuticals rose 72.22% to Rs 1.24 crore in the quarter ended June 2024 as against Rs 0.72 crore during the previous quarter ended June 2023. Sales rose 149.04% to Rs 126.91 crore in the quarter ended June 2024 as against Rs 50.96 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales126.9150.96 149 OPM %0.932.61 - PBDT2.291.61 42 PBT1.330.72 85 NP1.240.72 72 Powered by Capital Market - Live
Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 2.31%, vs industry avg of 9.04%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.16% to 0.11%
Lower than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of -6.54%, vs industry avg of 15.28%